Results 91 to 100 of about 130,730 (348)
No proton pump inhibitors? [PDF]
BMJ, 2007 Hickson et al have tried to introduce true scientific method in an area chiefly governed by sales tactics and mass advertising, but it is good to see their admission regarding …
openaire +1 more source
Tailoring the Properties of Functional Materials With N‐Oxides
Advanced Functional Materials, EarlyView.The properties of materials bearing N‐oxide groups are often dominated by the polar N+─O− bond. It provides hydrophilicity, selective ion‐binding, electric conductivity, or antifouling properties. Many of the underlying mechanisms have only recently been discovered, and the interest in N‐oxide materials is rapidly growing.
Timo Friedrich +5 more
wiley +1 more source
RENAL SAFETY OF PROTON PUMP INHIBITORS
Архивъ внутренней медицины, 2017 Proton pump inhibitors are a widely used in clinical practice, and are taken by millions of patients around the world for a long time. While proton pump inhibitors are well-tolerated class of drugs, the number of publications has been raised about ...
A. I. Dyadyk, T. E. Kugler
doaj +1 more source
Gut, 2000 Proton Pump Inhibitors . Edited by Olbe L. (Pp 264; illustrated; sFr198.00.) Switzerland: Birkhauser Verlag. 1999. ISBN 3 76435 897 1. The history of the development of drugs to treat the so-called acid related diseases makes a fascinating story, and the publication of this book addresses a significant chapter in that story.
openaire +1 more source
Advanced Functional Materials, EarlyView.This research presents a novel implantable bio‐battery, GF‐OsG, tailored for diabetic bone repair. GF‐OsG generates microcurrents in high‐glucose conditions to enhance vascularization, shift macrophages to the M2 phenotype, and regulate immune responses.
Nanning Lv +10 more
wiley +1 more source
Research of the assortment of the proton pump inhibitors on the regional drugs market
RUDN Journal of Medicine, 2013 Proton pump inhibitors are new most effective remedies for the treatment of gastric ulcer and duodenal ulcer. Analysis results of proton pump inhibitors assortment on the regional market are presented in the article.
O G Ivchenko +4 more
doaj
Pharmacogenetics of proton pump inhibitors
Медицинский совет, 2015 Proton pump inhibitors (PPI) are currently the most effective class of antisecretory drugs widely used in the treatment of non-ulcer dyspepsia, reflux esophagitis and GERD, peptic ulcer disease and H. pilory infection, as well as NSAID-associated gastric
M. V. Leonova
doaj +1 more source
Practical Strategies for Pharmacist Integration with Primary Care: A Workbook. [PDF]
, 2014 This workbook is a practical set of tips and resources to assist pharmacists in providing clinical pharmacy services to primary care providers and their patients.
Biddle, Michael A, Kennedy, Amanda G
core +1 more source
4D Printing of Self‐Immolative Polymers
Advanced Functional Materials, EarlyView.The integration of self‐immolative polymers (SIPs) into light‐based 3D printed structures is presented as a new “living” 4D printing strategy. By exploiting their metastability and stimuli‐responsiveness, SIP‐containing printed objects can undergo rapid and triggered degrowth under ambient conditions and subsequent regrowth through polymer ...
Johannes Markhart +3 more
wiley +1 more source
Safety of proton pump inhibitors
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2016 Aim of review. To present modern data on the possible mechanisms of development of side effects of the proton pump inhibitors (PPI). Summary. Proton pump inhibitors is the class of pharmaceuticals that block N+/K+-ATPase of gastric parietal cells.
Ye. A. Losik
doaj +1 more source